Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001213900-21-001414
Filing Date
2021-01-11
Accepted
2021-01-11 16:05:23
Documents
1
Period of Report
2021-01-07

Document Format Files

Seq Description Document Type Size
1 ownership.html 4  
1 ownership.xml 4 6439
  Complete submission text file 0001213900-21-001414.txt   7821
Mailing Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022
Business Address 880 3RD AVENUE, 12TH FLOOR NEW YORK NY 10022 646 876 3459
RELMADA THERAPEUTICS, INC. (Issuer) CIK: 0001553643 (see all company filings)

EIN.: 455401931 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 138 CANTERBURY LN BLUE BELL PA 19422
Business Address
TRAVERSA SERGIO (Reporting) CIK: 0001565832 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39082 | Film No.: 21520852